Yamaci, M. C. Et Al. 2025. Comparative Forced Degradation Study of Anticomplement C5 Biosimilar and Originator Monoclonal Antibodies. PHARMACEUTICALS , vol.18, no.4 , 1-18.

Yamaci, M. C., Pamukcu, C., Erdemgil, Y., Atik, A. E., Keles, Z. Z. Y., & Can, O., (2025). Comparative Forced Degradation Study of Anticomplement C5 Biosimilar and Originator Monoclonal Antibodies. PHARMACEUTICALS , vol.18, no.4, 1-18.

Yamaci, Merve Et Al. "Comparative Forced Degradation Study of Anticomplement C5 Biosimilar and Originator Monoclonal Antibodies," PHARMACEUTICALS , vol.18, no.4, 1-18, 2025

Yamaci, Merve C. Et Al. "Comparative Forced Degradation Study of Anticomplement C5 Biosimilar and Originator Monoclonal Antibodies." PHARMACEUTICALS , vol.18, no.4, pp.1-18, 2025

Yamaci, M. C. Et Al. (2025) . "Comparative Forced Degradation Study of Anticomplement C5 Biosimilar and Originator Monoclonal Antibodies." PHARMACEUTICALS , vol.18, no.4, pp.1-18.

@article{article, author={Merve Celik Yamaci Et Al. }, title={Comparative Forced Degradation Study of Anticomplement C5 Biosimilar and Originator Monoclonal Antibodies}, journal={PHARMACEUTICALS}, year=2025, pages={1-18} }